"i'm thinking this run-up's continuation is in anticipation of the 1/10/13 conference." Could be, but what could people be anticipating? It's going to be more of the same, don't you think - not anything bad, but nothing definitively positive, would be my guess. Perhaps a revised timeline on results from the current Afrezza trials, or updates from the other trials?

I still think you'll get a shot at lower price shares. One can also sell some puts, thereby shooting for a discount.

I do not understand this run-up, but happy to see it. It even has elevated volume associated with it, so perhaps there's something of substance coming relatively soon (or maybe another financing - LOL).